Walsh Lance Patrick
Eisenhower Medical Center, Rancho Mirage, California, USA.
Can J Urol. 2017 Jun;24(3):8859-8864.
Benign prostatic hypertrophy (BPH) affects an estimated 60% of men over the age of 50 and 90% of men over the age of 80. The prostatic urethral lift (PUL) is a safe and effective office-based procedure that is used worldwide for the treatment of BPH in men who are dissatisfied with medications due to side effects or lack of efficacy or don't want to have a transurethral resection of the prostate due to the side effects and invasiveness of the procedure. In 2012 Barkin et al, published the standard technique for the delivery of the Urolift implant. The objective of this article is to describe the current state of the art advanced techniques for the delivery of the UroLift implant.
良性前列腺增生(BPH)估计影响60%的50岁以上男性和90%的80岁以上男性。前列腺尿道悬吊术(PUL)是一种安全有效的门诊手术,在全球范围内用于治疗因副作用或疗效不佳而对药物治疗不满意,或因手术的副作用和侵入性而不想进行经尿道前列腺切除术的男性BPH患者。2012年,巴尔金等人发表了Urolift植入物植入的标准技术。本文的目的是描述UroLift植入物植入的当前先进技术状态。